Sanofi Draws Fire Over Cost of MS Drug Lemtrada

Sanofi draws fire over cost of MS drug Lemtrada

Filed under: drug treatment news 2011

The journal, which published the encouraging results of two late-stage Lemtrada tests on Thursday, also criticized the drugmaker's decision to withdraw leukemia therapy Campath, the same drug given at a different dosage, depriving MS patients who had …
Read more on Chicago Tribune